Indivior Pharmaceuticals, Inc 6-K, filed Jul 29, 2024
Indivior Pharmaceuticals, Inc. (INDV)
6-K
2024-07-29
For: 2024-07-29
View Original
Added on
April 10, 2026
About this 6-K
Indivior Pharmaceuticals, Inc filed this 6-K on July 29, 2024.
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
Washington, D.C. 20549
_____________________
FORM 6-K
_____________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of July 2024
Commission File Number: 001-37835
________________________________________
Indivior PLC
________________________________________
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
_______________________________
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F
Form
20-F ☒ Form 40-F ☐
|
|
EXHIBIT INDEX
|
Exhibit No.
|
Description of Exhibit
|
|
99.1
|
|
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
Indivior PLC
|
|
Date: July 29, 2024
|
/s/
Kathryn Hudson
|
|
|
Name:
Kathryn Hudson
|
|
|
Title:
Company Secretary
|
Exhibit
99.1
INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS
CLOSELY ASSOCIATED WITH THEM
The
Company announces that it received notification on July 28, 2024
that Jeff Burris, a PDMR and the Company's Chief Legal Officer,
acquired 760 Ordinary Shares of US$0.50 each in the Company
('Shares') at a price of $12.649 per share on July 26,
2024.
Following
this transaction, Jeff Burris has an interest in 760 shares in the
Company.
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||
|
a)
|
Name
|
Jeff
Burris
|
|
|
2
|
Reason for the notification
|
||
|
a)
|
Position/status
|
PDMR -
Chief Legal Officer
|
|
|
b)
|
Initial
notification /Amendment
|
Initial
notification
|
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
Indivior
PLC
|
|
|
b)
|
LEI
|
213800V3NCQTY7IED471
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description
of the financial instrument, type of instrument
Identification
code
|
Ordinary
Shares of US$0.50
GB00BN4HT335
|
|
|
b)
|
Nature
of the transaction
|
Purchase
of Shares
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
$12.65
|
660
|
||
|
$12.645
|
100
|
||
|
d)
|
Aggregated
information
-
Aggregated volume
-
Price
|
760
$12.649
|
|
|
e)
|
Date of
the transaction
|
July
26, 2024
|
|
|
f)
|
Place
of the transaction
|
Nasdaq
Global Select Market
|
|